Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Saritza Santos"'
Autor:
Saritza Santos, Maité Ramírez, Eric Miranda, Nelson Reyes, Osmarie Martínez, Maxier Acosta-Santiago, José M. Rivera, Miguel Otero
Publikováno v:
Journal of Immunology Research, Vol 2019 (2019)
Immunogenicity of DNA vaccines can be efficiently improved by adding adjuvants into their formulations. In this regard, the application of nano- and microparticles as vaccines adjuvants, or delivery systems, provides a powerful tool in designing mode
Externí odkaz:
https://doaj.org/article/a27d43722e224572a3493d9aff07cbf5
Autor:
Osmarie Martínez, Eric Miranda, Maite Ramírez, Saritza Santos, Carlos Rivera, Luis Vázquez, Tomás Sánchez, Raymond L Tremblay, Eddy Ríos-Olivares, Miguel Otero
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0123113 (2015)
BACKGROUND:The current live vaccinia virus vaccine used in the prevention of smallpox is contraindicated for millions of immune-compromised individuals. Although vaccination with the current smallpox vaccine produces protective immunity, it might res
Externí odkaz:
https://doaj.org/article/13c4e763ffc3414d9eeb4104b11f27a4
Autor:
Osmarie Martínez, Eric Miranda, Miguel Otero, Maite Ramírez, Ricardo Rodríguez, Saritza Santos, Willy D. Ramos-Perez
Publikováno v:
Vaccine
Poxviruses are complex dsDNA viruses with over 200 genes, many of them with unknown role in the stimulation of immune responses. Among these, the vaccinia virus (VACV) L3L ORF encodes an essential protein for the transcription of the VACV early genes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bbf296a06425ce352890d3c1c657124
http://europepmc.org/articles/PMC6065253
http://europepmc.org/articles/PMC6065253
Autor:
Saritza Santos, Eric Miranda, Osmarie Martínez, Ariana G. Bravo Cruz, Maite Ramírez, Miguel Otero, Joanna L. Shisler
Publikováno v:
Vaccine. 35:6007-6014
Smallpox is a disease caused by Variola virus (VARV). Although eradicated by WHO in 1980, the threat of using VARV on a bioterror attack has increased. The current smallpox vaccine ACAM2000, which consists of live vaccinia virus (VACV), causes compli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1023544345ba3171c9d415adf4691fd
https://doi.org/10.1016/j.vaccine.2017.05.091
https://doi.org/10.1016/j.vaccine.2017.05.091
Autor:
Maite Ramírez, José M. Rivera, Eric Miranda, Nelson Reyes, Maxier Acosta-Santiago, Miguel Otero, Saritza Santos, Osmarie Martínez
Publikováno v:
Journal of Immunology Research, Vol 2019 (2019)
Journal of Immunology Research
Journal of Immunology Research
Immunogenicity of DNA vaccines can be efficiently improved by adding adjuvants into their formulations. In this regard, the application of nano- and microparticles as vaccines adjuvants, or delivery systems, provides a powerful tool in designing mode
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::705fd5aa050db1a33f250f229ab88c5f
https://doaj.org/article/a27d43722e224572a3493d9aff07cbf5
https://doaj.org/article/a27d43722e224572a3493d9aff07cbf5
Autor:
Saritza Santos-Colón, Maite Ramírez, Eric Miranda, Nelson Reyes, Osmarie Martinez, Maxier Acosta, José Rivera, Miguel Otero
Publikováno v:
The Journal of Immunology. 200:125.3-125.3
DNA vaccines induce protective immune responses against several pathogens and tumor cells, but strategies to improve their effectiveness are still under study. Only two adjuvants have been licensed by the FDA, which increases the needs for the discov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::079151338b3e32023ff46aa8a0f187b9
https://doi.org/10.4049/jimmunol.200.supp.125.3
https://doi.org/10.4049/jimmunol.200.supp.125.3
Autor:
Luis L. Vázquez, Maite Ramírez, Eddy Ríos-Olivares, Tomás Sánchez, Eric Miranda, Osmarie Martínez, Miguel Otero, Saritza Santos, Raymond L. Tremblay, Carlos Rivera
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 4, p e0123113 (2015)
PLoS ONE, Vol 10, Iss 4, p e0123113 (2015)
BACKGROUND:The current live vaccinia virus vaccine used in the prevention of smallpox is contraindicated for millions of immune-compromised individuals. Although vaccination with the current smallpox vaccine produces protective immunity, it might res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12888af884e682e621b8e194e66ed66b
https://pubmed.ncbi.nlm.nih.gov/25875833
https://pubmed.ncbi.nlm.nih.gov/25875833